[11C]NNC-112
- Generic Name
- [11C]NNC-112
Brain Dopaminergic Signaling in Opioid Use Disorders
Early Phase 1
Recruiting
- Conditions
- Normal PhysiologyOpioid Use Disorders
- Interventions
- First Posted Date
- 2017-06-19
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Target Recruit Count
- 360
- Registration Number
- NCT03190954
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Positron Emission Tomography Imaging of Dopamine Receptors Using the Tracer [11C]NNC-112
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2004-07-28
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- National Institute of Mental Health (NIMH)
- Target Recruit Count
- 10
- Registration Number
- NCT00088517
- Locations
- 🇺🇸
National Institute of Mental Health (NIMH), Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath